Happy Thursday.

It's live. The Diligent Observer Exclusive opened this morning.

For over a year now, subscribers have asked me questions like “Are any of these companies still raising?” and “What else are you seeing?” and “How do I get connected with the founder?”

Well, now there’s a way. Every Tuesday, on top of the Thursday deals you already get, Exclusive members see:

I’m launching The Exclusive at a founding member rate for just the first 25 participants. If you've already reserved a seat, don’t worry, I’ve got your spot saved!

On to today’s issue:

Angel funding rounds announced in recent weeks, compiled from public sources or via direct announcement. These deals represent the elite few that survived an angel network’s vetting process. Note: I have not personally analyzed these companies and am sharing for informational purposes only.

📊 Angel Network Investment Tracker: 215 Deals, 111 Networks.

Participating Group: Park City Angels

AccuBreath is developing a handheld ventilator designed to replace the bag valve mask, a manual device used in emergencies to assist breathing that the company says can cause lung damage. Park City Angels recently announced an investment to support the product's advancement through the FDA's 510(k) pathway, a route for clearing devices similar to ones already on the market.

Spencer Madsen | Sandy, UT | July 2026 | Source

Participating Group: Atlanta Technology Angels

Connexus is developing an AI-powered platform that unifies real estate procurement, contracts, vendor management, and compliance into a single system for property owners and operators. The company says its platform brings efficiency and cost savings to a manual, fragmented workstream tied to vendor sourcing and contract management. Atlanta Technology Angels recently announced its support for the South Carolina-based startup, backing founder Devin Wirt and the team as they work to expand the platform across the multifamily, commercial, and hospitality real estate sectors.

Devin Wirt | Pawleys Island, SC | July 2026 | Source

Participating Group: Aggie Angel Network

BioPure, a subsidiary of Bondwell Technologies and a spinout of Texas A&M University, is developing scalable affinity matrices (purification media that bind and isolate target proteins) designed to replace traditional resin columns used in the manufacturing of biologics, or protein-based therapeutics. The company says its approach makes biomanufacturing faster and more cost-effective. The Aggie Angel Network recently invested in Q2 2026, with funds earmarked for scaling manufacturing and distributing test samples to prospective customers.

David Howell | College Station, TX | June 2026 | Source

🃏 Pulling a CRAZY RARE business card: I’m dying. Hilarious short from Good Work this week. I recently discovered there’s a whole world of creators where all they do is open sealed trading cards for a living, so this is particularly timely.

🏗️ Pro Rata? No Thanks: Thoughtful contrarian take. Hunter Walk says it’s better to effectively skip reserves, focus on getting more shots on goal, and let secondaries handle the rest.

📊 A Workforce Splitting in Two: Lenny Rachitsky and Noam Segal just released their second annual survey on how tech workers feel about their jobs and careers. Piles of really interesting data here, but one tidbit that stood out to me: “Only 22% worry about ‘losing my job to AI.’ Far more worry about being expected to do more for the same pay (51%)…”

Ben framed it pretty directly: Israel is not a place to scale a company. It's where a founder develops and validates new technology before shipping it to the world.

Takeaway: For tech companies based in the region, it is extremely important to ask: "Where is the exit market and does this team have a path there?"

P.S. “Tachlis,” a Hebrew word that roughly translates to “get to the bottom line,” is my new favorite word.

Want more? Check out my full conversation with Ben 👇

Listen now on Apple Podcasts, Spotify, YouTube, and more.

Thanks for reading - have a great week.

-Andrew

If you’re finding this newsletter valuable, share it with a friend, and consider subscribing if you haven’t already. You can also find me on LinkedIn and X.

Advertise with The Diligent Observer.